E. Schutyser

发表

Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes

J. Van Damme, A. Richmond, E. Schutyser, 2005, Journal of leukocyte biology.

TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis

G. Opdenakker, P. Proost, E. Schutyser, 2006, Laboratory Investigation.

Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis

G. Opdenakker, K. Geboes, E. Schutyser, 2001, European journal of immunology.

The CXC Chemokine GCP-2/CXCL6 Is Predominantly Induced in Mesenchymal Cells by Interleukin-1β and Is Down-Regulated by Interferon-γ: Comparison with Interleukin-8/CXCL8

G. Opdenakker, P. Proost, K. Geboes, 2003, Laboratory Investigation.

Chemokine receptor internalization and intracellular trafficking.

A. Richmond, J. Sai, E. Schutyser, 2005, Cytokine & growth factor reviews.

Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies

M. Parmentier, G. Opdenakker, P. Proost, 2006, Arthritis research & therapy.

Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.

J. Van Damme, A. Richmond, E. Schutyser, 2007, European cytokine network.

Hypoxia enhances CXCR 4 expression in human microvascular endothelial cells and human melanoma cells

A. Richmond, E. Schutyser, J. Damme, 2007 .

Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration.

M. Parmentier, P. Proost, J. Van Damme, 2007, Blood.

Proteolytic processing of CXCL 11 by CD 13 / aminopeptidase N impairs CXCR 3 and CXCR 7 binding and signaling and reduces lymphocyte and endothelial cell migration

M. Parmentier, P. Proost, E. Schutyser, 2007 .

CINACALCET FOR MANAGING SECONDARY HYPERPARATHYROIDISM IN DIALYSIS PATIENTS IN CLINICAL PRACTICE IN BELGIUM: A 16-MONTH OBSERVATIONAL STUDY (ECHO-B)

M. Jadoul, R. Vanholder, B. Maes, 2013, Acta clinica Belgica.

The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.

E. De Clercq, P. Proost, J. Van Damme, 1999, The Journal of clinical investigation.

Carcinoma cell-derived chemokines and their presence in oral fluid.

R. Jacobs, P. Proost, J. Van Damme, 2009, European journal of oral sciences.

Synergistic induction of CXCL9 and CXCL11 by Toll‐like receptor ligands and interferon‐γ in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids

G. Opdenakker, P. Proost, E. Schutyser, 2004, Journal of leukocyte biology.

Stimulation of angiostatic platelet factor‐4 variant (CXCL4L1/PF‐4var) versus inhibition of angiogenic granulocyte chemotactic protein‐2 (CXCL6/GCP‐2) in normal and tumoral mesenchymal cells

R. Sciot, G. Opdenakker, P. Proost, 2007, Journal of leukocyte biology.

Synergy between Coproduced CC and CXC Chemokines in Monocyte Chemotaxis through Receptor-Mediated Events

M. Parmentier, J. Springael, P. Proost, 2008, Molecular Pharmacology.

Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.

P. Proost, I. De Meester, J. Van Damme, 2000, Blood.

The CC chemokine CCL20 and its receptor CCR6.

J. Van Damme, E. Schutyser, S. Struyf, 2003, Cytokine & growth factor reviews.

Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma*

P. Allavena, A. Mantovani, G. Opdenakker, 2002, The Journal of Biological Chemistry.

Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation

G. Opdenakker, P. Proost, J. Van Damme, 2008, The Journal of experimental medicine.

Regulated Production and Molecular Diversity of Human Liver and Activation-Regulated Chemokine/Macrophage Inflammatory Protein-3α from Normal and Transformed Cells1

P. Proost, J. Van Damme, E. Schutyser, 2000, The Journal of Immunology.

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.

M. Parmentier, C. Durinx, G. Opdenakker, 2001, Blood.

PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.

G. Opdenakker, P. Proost, J. Van Damme, 2003, The American journal of pathology.

Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.

G. Opdenakker, J. Van Damme, S. Noppen, 2010, Human pathology.

Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.

A. Richmond, E. Schutyser, N. Neel, 2006, Cancer research.

Cleavage by CD 26 / dipeptidyl peptidase IV converts the chemokine LD 78 b into a most efficient monocyte attractant and CCR 1 agonist

P. Proost, E. Schutyser, J. Damme, 2000 .

Posttranslational processing of chemokines.

P. Proost, J. Van Damme, E. Schutyser, 2004, Methods in molecular biology.

Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants.

G. Opdenakker, P. Proost, J. Van Damme, 2001, Biochemistry.